|
1
|
Rehfeld JF: The new biology of
gastrointestinal hormones. Physiol Rev. 78:1087–108. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hauso O, Gustafsson B, Kidd M, Waldum H,
Drozdov I, Chan A and Modlin I: Neuroendocrine tumour epidemiology.
Cancer. 113:2655–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rindi G, Petrone G and Inzani F: The 2010
WHO classification of digestive neuroendocrine neoplasms: a
critical appraisal four years after its introduction. Endocr
Pathol. 25:186–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rindi G, Arnoid R, Bosman FT, Capella C,
Klimstra DS, Kloppel G, Komminorth P and Solcia E: Nomeclature and
classification of the neuroendocrine neoplasms of the digestive
system. In: WHO Classification of Tumours of the Digestive System.
4th. IARC Press; Lyon, France: pp. 13–14. 2010
|
|
5
|
Yamaguchi T, Fujimori T, Tomita S,
Ichikawa K, Mitomi H, Ohno K, Shida Y and Kato H: Clinical
validation of the gastrointestinal NET grading system: Ki67 index
criteria of the WHO 2010 classification is appropriate to predict
metastasis or recurrence. Diagn Pathol. 8(65)2013.
|
|
6
|
Karakuş E, Helvacı A, Ekinci O and and
Dursun A: Comparison of WHO 2000 and WHO 2010 classifications of
gastroenteropancreatic neuroendocrine tumours. Turk J
Gastroenterol. 25:81–87. 2014. View Article : Google Scholar
|
|
7
|
Celotti A, Pulcini G, Schieppati M,
Ministrini S, Berruti A and and Ronconi M: An unususal case of a
well-differentiated neuroendocrine tumor of the ileum with
peritoneal carcinomatosis : A case report. World J Surg Oncol.
13:1353–1361. 2015. View Article : Google Scholar
|
|
8
|
Langley K: The neuroendocrine consept
today. Ann NY Acad Sci. 733:1–17. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warner RR: Enteroendocrine tumors other
than carcinoid. A review of clinically significant advances.
Gastroenterology. 128:1668–1684. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uberg K: Carcinoid tumors: Current
concepts in diagnosis and treatment. The Oncologist. 3:339–45.
1998.PubMed/NCBI
|
|
11
|
Griniatsos J and Michail O: Appendiceal
neuroendocrine tumors. Resent insights and clinical implications.
World J Gastrointest Oncol. 2:192–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ni S and Sheng W, Du X and Sheng W:
Pathologic research update of colorectal neuroendocrine tumors.
World J Gastroenterol. 16:1713–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Konishi T, Watahabe T, Nagawa H, Oya H,
Ueno M, Kuroyanagi H, Fujimoto Y, Akiyoshi T, Yamaguchi T and Muto
T: Treatment of colorectal carcinoids. A new paradigm. World J
Gastrointest Surg. 2:153–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Begum N, Maasberg S, Plockinger U, Anlauf
M, Rinke A, Popperl G, Lehnert H, Izbicki HR, Krausch M, Vashist
YK, et al: Zentralbl Chir. 139:276–283. 2014.PubMed/NCBI
|
|
15
|
Modlin I. M, Shapiro MD and Kidd M:
Signified Oberdorfer. Origins and perspectives of carcinoid tumors.
Human Pathology. 35:1440–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krols LK: Carcinoid tumors and the
carcinoid syndrome. What is new in therapeutic pipeline. The
carcinoid cancer foundation: carcinoid symposium 2002. http://www.carcinoid.orgJuly 8–2017
|
|
17
|
Oberg K: The genetics of neuroendocrine
tumors. Semin Oncol. 40:37–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaltsas G, Besser M and Grossman A: The
diagnosis and medical management of advanced neuroendocrine tumors.
Endocr Rev. 25:458–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jamalli M and Chetty R: Predicting
prognosis on gastroentero-pancreatic neuroendocrine tumors. An
overview and the value of Ki 67 immunostaining. Endocr Pathol.
19:282–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al:
One hundred years after ‘carcinoid’. Epidemiology of and prognostic
factors for neuroendocrine tumors in 38,525 cases in the United
States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Well-Differentiated Neuroendocrine Tumours
of the Gastrointestinal Tract. Union for International Cancer
Control (UICC). TNM Classification of Malignant Tumours. 8th.
Wiley-Blackwell; Hoboken, NJ: pp. 96–99. 2017
|
|
22
|
Khan MS, Kirkwood A, Tsigani T,
Garcia-Hernnandez I, Hartley JA, Caplin ME and Meyer T: Circulating
tumor cells as prognostic markers in neuroendocrine tumors. J Clin
Oncol. 31:365–372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mei D, Alexandria T and James C: New
strategies for advanced neuroendocrine tumors. CCR. 18:1830–37.
2012.
|
|
24
|
Burke AP, Thomas RM, Elsayed AM and Sobin
H: Carcinoids of jejunum and ileum. Cancer. 79:1086–93. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yantiss RK, Odze RD, Farraye FA and
Rosenberg AE: Solitary versus multiple carcinoid tumors. A clinical
and pathologic review of 68 cases. Am J Surg Pathol. 27:811–817.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jann H, Roll S, Couverald A, Hentic O,
Pavel M, Muller-Nordhorn J, Koch M, Rocken C, Rindi G, Ruszniewski
P, et al: Neuroendocrine tumors of midgut- hindgut origin.
Tumor-node-metastasis classification determines clinical outcome.
Cancer. 117:3332–3341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi Ch, Adsay V, Bergsland EM, Berlin J,
Branton PA, Fitzgibbons PL, Frankel WL, Kakar S, Klepeis V,
Klimstra DS, et al: Protocol for the Examination of Specimens from
Patients with Neuroendocrine Tumors (Carcinoid Tumors) of the
Jejunum and Ileum. Version: Jejunum/Ileum NET 1.0.0.0. Cancer
protocol templates. College of American Pathologists (CAP), 2017.
http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/cp-jejunal-Ileal-net-17protocol-1000.pdfJuly
8–2017
|
